NASDAQ | ETF
The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund"s investment sub-adviser, under the supervision of the adviser.
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
6XC | SOLENO THERAPEUT. DL-001 | Healthcare | Biotechnology | 7.56% |
BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 7.49% |
BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 6.06% |
RDNT | RadNet Inc | Healthcare | Diagnostics & Research | 5.92% |
MMSI | Merit Medical Systems Inc | Healthcare | Medical Instruments & Supplies | 5.36% |
TMDX | TransMedics Group Inc | Healthcare | Medical Devices | 5.07% |
TVTX | Travere Therapeutics Inc | Healthcare | Biotechnology | 4.82% |
LIVN | LivaNova PLC | Healthcare | Medical Devices | 4.62% |
COLL | Collegium Pharmaceutical Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.52% |
RARE | Ultragenyx | Healthcare | Biotechnology | 4.47% |
ATEC | Alphatec Holdings Inc | Healthcare | Medical Devices | 3.95% |
INSM | Insmed Inc | Healthcare | Biotechnology | 3.93% |
MDGL | Madrigal Pharmaceuticals Inc | Healthcare | Biotechnology | 3.82% |
GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 3.56% |
WVE | Wave Life Sciences Ltd | Healthcare | Biotechnology | 3.18% |
ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 3.16% |
ETNB | 89bio Inc | Healthcare | Biotechnology | 2.92% |
AKRO | Akero Therapeutics Inc | Healthcare | Biotechnology | 2.33% |
NEO | NeoGenomics Inc | Healthcare | Diagnostics & Research | 2.26% |
SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 2.15% |